Join
Live feed
·
PRReleasevia Quantisnow
Ligand Pharmaceuticals Incorporated logo

Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031

ByQuantisnow·Wall Street's wire, on your screen.
LGND· Ligand Pharmaceuticals Incorporated
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LGND (Ligand Pharmaceuticals Incorporated) and more on Quantisnow.